A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus

被引:52
作者
Paragas, J [1 ]
Whitehouse, CA [1 ]
Endy, TP [1 ]
Bray, M [1 ]
机构
[1] USA, Med Res Inst Infect Dis, Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA
关键词
antiviral; Crimean-Congo hemorrhagic fever virus; ribavirin; high-throughput screening; bunyavirus; tick-borne disease;
D O I
10.1016/j.antiviral.2003.11.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne virus that is emerging as a significant human pathogen in many regions of the world, including Africa, Asia, and Europe. In this report, we describe a simple screening method for discovering new antiviral compounds directed against CCHFV. Antiviral activity was determined by assaying infected SW-13 cells (human adrenal gland carcinoma) for protection from cytopathic effect (CPE). By using an in vitro neutral red uptake assay, we were able to quantitatively measure CPE induced by CCHFV As a proof of concept, we used this method to evaluate the antiviral activity of ribavirin and a series of structural analogs (ribamidine, 6-azauridine, selenazofurin, and tiazofurin) against four geographically diverse strains of CCHFV. Ribavirin inhibited the replication of CCHFV as reported previously using plaque reduction assays. One drug, ribamidine, showed antiviral activity that was 4.5-to 8-fold less than that of ribavirin, and the other three drugs (6-azauridine, selenazofurin, and tiazofurin) did not show significant antiviral activity. There were no significant differences in drug sensitivities among the CCHFV strains. Development of this simple and reliable assay will potentially allow high-throughput screening for discovering additional antiviral drugs to combat this important public health threat. Published by Elsevier B.V.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 22 条
[1]   Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections [J].
Baker, R ;
Bray, M ;
Huggins, JW .
ANTIVIRAL RESEARCH, 2003, 57 (1-2) :13-23
[2]   Hemorrhagic fever viruses as biological weapons - Medical and public health management [J].
Borio, L ;
Inglesby, T ;
Peters, CJ ;
Schmaljohn, AL ;
Hughes, JM ;
Jahrling, PB ;
Ksiazek, T ;
Johnson, KM ;
Meyerhoff, A ;
O'Toole, T ;
Ascher, MS ;
Bartlett, J ;
Breman, JG ;
Eitzen, EM ;
Hamburg, M ;
Hauer, J ;
Henderson, A ;
Johnson, RT ;
Kwik, G ;
Layton, M ;
Lillibridge, S ;
Nabel, GJ ;
Osterholm, MT ;
Perl, TM ;
Russell, P ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (18) :2391-2405
[3]   NOSOCOMIAL OUTBREAK OF VIRAL HEMORRHAGIC-FEVER CAUSED BY CRIMEAN HEMORRHAGIC-FEVER CONGO VIRUS IN PAKISTAN, JANUARY 1976 [J].
BURNEY, MI ;
GHAFOOR, A ;
SALEEN, M ;
WEBB, PA ;
CASALS, J .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1980, 29 (05) :941-947
[4]   CRIMEAN-CONGO HEMORRHAGIC-FEVER TREATED WITH ORAL RIBAVIRIN [J].
FISHERHOCH, SP ;
KHAN, JA ;
REHMAN, S ;
MIRZA, S ;
KHURSHID, M ;
MCCORMICK, JB .
LANCET, 1995, 346 (8973) :472-475
[6]   The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran [J].
Mardani, M ;
Jahromi, MK ;
Naieni, KH ;
Zeinali, M .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (12) :1613-1618
[7]   Genetic diversity of the M RNA segment among Crimean-Congo hemorrhagic fever virus isolates in China [J].
Morikawa, S ;
Qing, T ;
Zhao, XQ ;
Saijo, M ;
Kurane, I .
VIROLOGY, 2002, 296 (01) :159-164
[8]  
Nichol S.T., 2001, VIROLOGY, V2, P1603
[9]   Genetic detection and isolation of Crimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia [J].
Papa, A ;
Bozovi, B ;
Pavlidou, V ;
Papadimitriou, E ;
Pelemis, M ;
Antoniadis, A .
EMERGING INFECTIOUS DISEASES, 2002, 8 (08) :852-854
[10]   Genetic characterization of the M RNA segment of Crimean Congo hemorrhagic fever virus strains, China [J].
Papa, A ;
Ma, BJ ;
Kouidou, S ;
Tang, Q ;
Hang, CS ;
Antoniadis, A .
EMERGING INFECTIOUS DISEASES, 2002, 8 (01) :50-53